84
Participants
Start Date
August 14, 2025
Primary Completion Date
June 30, 2028
Study Completion Date
September 30, 2028
Pregnenolone
Pregnenolone 250 mg BID x 14 DAYS, followed by Pregnenolone 500 mg BID x 14 DAYS, followed by Pregnenolone 1000 mg BID x thereafter for the remainder of the 8-week trial.
Placebo
Same as active comparator, except placebo dispensed
RECRUITING
Durham VA Medical Center, Durham, NC, Durham
VA Office of Research and Development
FED